Company intelligence / Profile preview

Mypher Pharmaceuticals

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

Mypher Pharmaceuticals is a San Diego-based biotechnology company dedicated to transforming the treatment of iron deficiency and iron deficiency anemia. The company is developing a proprietary oral iron therapy, MYP-101, which is engineered to provide superior bioavailability and reduced gastrointestinal toxicity compared to standard-of-care iron salts. Mypher's approach focuses on a novel iron-delivery mechanism that mimics natural iron absorption pathways. The company aims to address the significant unmet need for patients who are intolerant to or fail current oral iron treatments.

Therapeutic areas: Hematology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Mypher Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mypher Pharmaceuticals.

Explore the full profile